Minidose Warfarin and Failure to Prevent Deep Vein Thrombosis After Joint Replacement Surgery Despite Inhibiting the Postoperative Rise in Plasminogen Activator Inhibitor Activity

Abstract

In a prospective randomised study in patients undergoing elective total hip or knee replacement surgery, the antithrombotic efficacy of fixed-minidose warfarin (1 mg daily commenced 7 days before surgery) was compared with that of subcutaneous calcium heparin (Calciparine, 5,000 IU t.d.s. commenced 2 h before surgery). Both regimens were continued until venography of the operated limb was performed 9-14 days postsurgery. Venographically detected deep vein thromboses (DVTs) occurred in 15 of the 31 patients (48.4%) in the minidose warfarin group and in eight of the 37 patients (21.6%) receiving heparin. The absolute difference in the incidence of DVT was 26.8% in favour of heparin (95%l confidence interval [CI] -4.&--48.8%; p = 0.039). Proximal DVTs were detected in three patients receiving minidose warfarin and in none of those on heparin (p = 0.09). Minidose warfarin appeared to prevent the postoperative rise in the activity of plasminogen activator inhibitor (PAI) that occurred with heparin, although preoperative PAI activity was greater in the warfarin group. The prothrombin time (PT) and activated partial thromboplastin time (APTT) were within the normal range on the day of surgery in both treatment groups. Postsurgery, the minidose warfarin regimen produced a small, but significant prolongation of the PT compared with the group receiving heparin, In contrast to heparin, 1 mg warfarin daily failed to prevent postoperative acceleration of the APTT. There was no significant difference between the two regimens in bleeding complications. In conclusion, the fixed-minidose warfarin regimen cannot be recommended for prevention of DVT after hip or knee replacement surgery. Inhibition of the postoperative rise in PAI activity appears not to protect against DVT after major joint replacement surgery. Key Words: Warfarin—Heparin—Deep vein thrombosis prophylaxis—Coagulation—Fibrinolysis— Plasminogen activator inhibitor.

Get full access to this article

View all access options for this article.

References

Hyers TM , Hull RD , Weg JG Antithrombotic therapy for venous thomboembolic disease. Chest 1986;89(suppl 2):26-35.

Evarts CM , Feil EJ Prevention of thromboembolic disease after elective surgery of the hip. J Bone Joint Surg (Am) 1971;53: 1271-80.

Bergqvist D. , Elvelin R. , Eriksson U. , Hjelmstedt A. Thrombosis following elective hip arthroplasty: a study using phlebography and 125I-fibrinogen test. Acia Orthop Scand 1976; 45:549-57.

Harris WH , Salzman EW , Athanasoulis CA , Waltman AC , Strauss HW Aspirin prophylaxis of venous thromboembolism after total hip replacement . N Engl J Med 1977;297: 1246-9.

Moskovitz PA , Ellenberg SS , Feder HL , et al. Low-dose heparin for prevention of venous thromboembolism in total hip arthroplasty and surgical repair of hip fractures. J Bone Joint Surg (Am) 1978 ;60:1065-70.

Rogers PH , Walsh PN , Marder VJ , et al. Controlled trial of low-dose heparin and sulfinpyrazone to prevent venous thromboembolism after operation on the hip. J Bone Joint Surg (Am) 1978;60;758-62.

Turpie Agg , Levine MN , Hirsh J. , et al. A randomized controlled trial of a low-molecular-weight heparin (Enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery. N Engi J Med 1986;315:925-9.

Sheppeard H. , Henson J. , Ward DJ , O'Connor BT A clinicopathological study of fatal pulmonary embolism in a specialist orthopaedic hospital. Arch Orthop Trauma Surg 1981;99: 65-71.

Hull R. , Delmore TJ , Hirsh J. , et al. Effectiveness of intermittent pulsatile elastic stockings for the prevention of calf and thigh vein thrombosis in patients undergoing elective knee surgery. Thromb Res 1979;16:37-45.

10.

McKenna R. , Galante J. , Bachmann F. , Wallace DL , Kaushal SP , Meredith P. Prevention of venous thromboembolism after total knee replacement by high-dose aspirin or intermittent calf and thigh compression. Br Med J 1980;280:514-7.

11.

Stulberg BN , Insall JN , Williams GW , Ghelman B. Deep-vein thrombosis following total knee replacement: an analysis of 638 arthroplasties. J Bone Joint Surg (Am) 1984;66: 194-201.

12.

Collins R. , Scrimgeour A. , Yusuf S. , Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin: overview of results of randomised trials in general, orthopedic and urologic surgery. N Engl J Med 1988:318:1162-73.

13.

Leyvraz PF , Richard J. , Bachmann F. , et al. Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep vein thrombosis after total hip replacement. N Engl J Med 1983;309:954-8.

14.

Francis CW , Marder VJ , Evarts CM , Yaukoolbodi S. Two-step warfarin therapy: prevention of postoperative venous thrombosis without excessive bleeding. JAMA 1983;249: 374-8.

15.

Paiement G. , Wessinger SJ , Waltman AC , Harris WH Low dose warfarin versus external pneumatic compression for prophylaxis against venous thromboembolism following total hip replacement. J Arthroplasty 1987;2:23-6.

16.

Morris GK Prevention of venous thromboembolism: a survey of methods used by orthopaedic and general surgeons. Lancet 1980 ;2:572-4.

17.

Laverick MD , Croal SA , Mollan Rab. Orthopaedic surgeons and thromboprophylaxis . Br Med J 1991;303:549-50.

18.

Consensus Conference. Prevention of venous thrombosis and pulmonary embolism. JAMA 1986 ;256:744-9.

19.

Clagett GP , Anderson FA Jr , Levine MN , Salzman EW , Wheeler HB Prevention of venous thromboembolism. Chest 1992;102:suppl:391S-407S.

20.

Poller L. , McKeman A. , Thomson JM , Elstein M. , Hirsch PJ , Jones JB Fixed mini-dose warfarin: a new approach to prophylaxis against venous thrombosis after major surgery. Br Med J 1987 ;295 - 1309-12.

21.

MacCallum PK , Thomson JM , Poller L. Effects of fixed minidose warfarin on coagulation and fibrinolysis following major gynaecological surgery . Thromb Haemost 1990;64: 511-5.

22.

Bern MM , Lokich JJ , Wallach SR , et al. Very low doses of warfarin can prevent thrombosis in central venous catheters: a randomized prospective trial. Ann Intern Med 1990;112: 423-8.

23.

Bettmann MA Contrast phlebography. In: Hirsh J. ed. Venous thrombosis and pulmonary embolism: diagnostic methods . Edinburgh: Churchill Livingstone , 1987:20-32.

24.

Thomson JM , Poller L. The activated partial thromboplastin time. In: Thomson JM , ed. Blood coagulation and haemostasis: a practical guide, 3rd ed. Edinburgh : Churchill Livingstone, 1985:301-39.

25.

Chmielewska J. Ranby M , Wiman B. Evidence for a rapid inhibitor to tissue plasminogen activator in plasma. Thromb Res 1983;31:427-36.

26.

Kluft C. Verheijen JH , Rijken DC , Chang Gtg , Jie Afh , Onkelix C. Diurnal fluctuations in the activity of the fast-acting t-PA inhibitor, In: Davidson JF , Donati MB , Coccheri S , eds. Progress in fibrinolysis , vol. 7. Edinburgh: Churchill Livingstone, 1985:117-9.

27.

Koppert PW , Koopman J. , Haverkate F. , Nieuwenhuizen W. Production and, characterization of amonoclonal antibody reactive with a specific neoatigenic determinant (comprising Bβ54-118) in degradation products of fibrin and fibrinogen. Blood 1986 ;68;437-41.

28.

Koppert PW , Kuipers W. , Hoegee -de Nobel E, Brommer EJP, Koopman J, Nieuwenhuizen W. A quantitative enzyme immunoassay for primary, fibrinolysis products in plasma. Thromb Haemost 1987;57:25-8.

29.

Koppert PW , Hoegee-de Nobel E , Nieuwenhuizen W. A monoclonal antibody-based enzyme immunoassay for fibrin degradation products in plasma. Thromb Haemost 1988;59: 310-5.

30.

Armitage P. , Berry G. Statistical methods in medical research, 2nd ed. Oxford: Blackwell Scientific Publications , 1987:93-140.

31.

Box Gep , Cox DR An analysis of transformations. J R Statist Soc B 1964;26:211-52.

32.

Winer BJ Statistical principles in experimental design, 2nd ed. New York: McGraw-Hill, 1971:149-305.

33.

Bulpitt CJ Confidence intervals. Lancet 1987;1:494-7.

34.

Francis CW , Pellegrini VD Jr, Marder VJ , et al. Comparison of warfarin and external pneumatic compression in prevention of venous thrombosis after total hip replacement. JAMA 1992;267:2911-5.

35.

Hull RD , Raskob G. , Pineo G. , et al. A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation. N Engl J Med 1993;329.1370-6.

36.

Leiline M. , Hirsh J. , Gent M. , et al. Double-blind randomised trial of very-tow-dose warfarin for prevention of thromboembolism in stage IV breast cancer. Lancet 1994;343:886-9.

37.

Dale C. , Gallus A. , Wycherlely A. , Langlois S. , Howie D. Prevention of venous thrombsis With minidose warfarin after joint replacement . Br Med J 1991;303:224.

38.

Fordyce Mjf , Baker AS , Staddon G.E. Efficacy of fixed minidose warfarin prophylaxis in total hip replacement. Br Med J 1991;303:219-20.

39.

Lensing Awa , Hirsh J. 125I-fibrinogen leg scanning: reassessment of its role for the diagnosis of venous thrombosis in post-operative patients . Thromb Haemost 1993;69:2-7.

40.

Feller JA , Parkin JD , Phillips GW , Hannon PJ , Hennessy O. , Huggins RM Prophylaxis against venous thrombosis after total hip arthroplasty . Aust NZ J Surg 1992;62:606-10.

41.

Paramo JA , Alfano MJ , Rocha E. Postoperative changes in the plasmatic levels of tissue-type plasminogen activator and its fast acting inhibitor: relationship to deep vein thrombosis and influence of prophylaxis. Thromb Haemost 1985;54: 713-6.

42.

Ericksson BI , Eriksson E. , Gyzander E. , Teger-Nilsson A-C. , Risberg B. Thrombosis after hip replacement: relationship to the fibrinolytic system. Acta Orthop Scand 1989;60:159-63.

43.

Poller L. , Tabemer DA , Sandilands DG , Galasko Csb. An evaluation of APTT monitoring of low-dose heparin dosage in hip surgery . Thromb Haemost 1982;47:50-3.